Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis

被引:7
|
作者
Balmuri, Nayimisha [1 ,2 ]
Soulsby, William Daniel [3 ]
Cooley, Victoria [2 ]
Gerber, Linda [2 ]
Lawson, Erica [3 ]
Goodman, Susan [1 ,2 ]
Onel, Karen [1 ,2 ]
Mehta, Bella [1 ,2 ]
机构
[1] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[2] Weill Cornell Med, New York, NY 10065 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
HEALTH DISPARITIES; RADIOGRAPHIC PROGRESSION; SOCIOECONOMIC MEASURES; DISEASE OUTCOMES; CHILDREN; CARE; ACCESS; DELAY;
D O I
10.1186/s12969-021-00610-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The impact of social determinants of health on children with polyarticular juvenile idiopathic arthritis (pJIA) is poorly understood. Prompt initiation of treatment for pJIA is important to prevent disease morbidity; however, a potential barrier to early treatment of pJIAs is delayed presentation to a pediatric rheumatologist. We examined the impact of community poverty level, a key social determinant of health, on time from patient reported symptom onset to first pediatric rheumatology visit among pJIA patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. Methods: This is a cohort study of pJIA patients in the CARRA registry who lived in the United States from July 2015-February 2020. The primary exposure was community poverty level derived by geocoding patient addresses. The primary outcome was time to first rheumatology appointment. Kaplan-Meier analysis was performed to analyze time to first rheumatologist visit, stratified by community poverty and family income. Log-rank tests were used to identify differences between groups. Adjusted cox proportional-hazards models were used to determine the relationship between community poverty level and time from onset of disease symptoms to date first seen by rheumatologist. Results: A total of 1684 patients with pJIA meeting study inclusion and exclusion criteria were identified. Median age of onset of pJIA was 7 years (IQR 3, 11), 79% were female, 17.6% identified as minority race and/or ethnicity, and 19% were from communities with >= 20% community poverty level. Kaplan-Meier analysis by community poverty level (< 20% vs >= 20%) yielded no significant differences with time to initial presentation to a pediatric rheumatologist (p = 0.6). The Cox proportional hazards model showed that patients with >= 20% community poverty level were 19% less likely (adjusted HR 0.81, 95% CI 0.67-0.99, p = 0.038) to be seen by a rheumatologist compared to patients with < 20% community poverty level, at the same time point, after adjusting for sex, race/ethnicity, insurance, education level, morning stiffness, RF status, and baseline CHAQ. Conclusion: In this study of pJIA patients in the CARRA registry, increased community poverty level is associated with longer time to presentation to a pediatric rheumatologist after symptom onset.
引用
收藏
页数:9
相关论文
共 27 条
  • [21] Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry
    Foeldvari, Ivan
    Becker, Ingrid
    Horneff, Gerd
    ARTHRITIS CARE & RESEARCH, 2015, 67 (11) : 1529 - 1535
  • [22] Switched Memory B Cells Are Increased in Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis and Their Change Over Time Is Related to Response to Tumor Necrosis Factor Inhibitors
    Marasco, Emiliano
    Aquilani, Angela
    Cascioli, Simona
    Moneta, Gian Marco
    Caiello, Ivan
    Farroni, Chiara
    Giorda, Ezio
    D'Oria, Valentina
    Marafon, Denise Pires
    Magni-Manzoni, Silvia
    Carsetti, Rita
    De Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (04) : 606 - 615
  • [23] Analysis of the Immunogenicity from Abatacept-Treated Pediatric Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: Findings From Two Phase III Clinical Trials
    Mora, Johanna R.
    Wong, Robert
    Shaikh, Mehmooda
    Askelson, Margarita
    ACR OPEN RHEUMATOLOGY, 2022, 4 (02) : 177 - 186
  • [24] Risk of Serious Infection in Juvenile Idiopathic Arthritis Patients Associated With Tumor Necrosis Factor Inhibitors and Disease Activity in the German Biologics in Pediatric Rheumatology Registry
    Becker, Ingrid
    Horneff, Gerd
    ARTHRITIS CARE & RESEARCH, 2017, 69 (04) : 552 - 560
  • [25] How common is remission in rheumatoid factor-positive juvenile idiopathic arthritis patients? The multicenter Pediatric Rheumatology Academy (PeRA) research group experience
    Ozdel, Semanur
    Sonmez, Hafize Emine
    Caglayan, Sengul
    Akgun, Ozlem
    Aydin, Tuncay
    Baba, Ozge
    Bagrul, Ilknur
    Yener, Gulcin Otar
    Ozturk, Kubra
    Demir, Ferhat
    Yildirim, Deniz Gezgin
    Karadag, Serife Gul
    Baglan, Esra
    Cakan, Mustafa
    Kalyoncu, Mukaddes
    Makay, Balahan Bora
    Unsal, Sevket Erbil
    Bakkaloglu, Sevcan
    Bulbul, Mehmet
    Sozeri, Betul
    Ayaz, Nuray Aktay
    PEDIATRIC RHEUMATOLOGY, 2023, 21 (01)
  • [26] Clinically Inactive Disease in a Cohort of Children with New-onset Polyarticular Juvenile Idiopathic Arthritis Treated with Early Aggressive Therapy: Time to Achievement, Total Duration, and Predictors
    Wallace, Carol A.
    Giannini, Edward H.
    Spalding, Steven J.
    Hashkes, Philip J.
    O'Neil, Kathleen M.
    Zeft, Andrew S.
    Szer, Ilona S.
    Ringold, Sarah
    Brunner, Hermine I.
    Schanberg, Laura E.
    Sundel, Robert P.
    Milojevic, Diana S.
    Punaro, Marilynn G.
    Chira, Peter
    Gottlieb, Beth S.
    Higgins, Gloria C.
    Ilowite, Norman T.
    Kimura, Yukiko
    Johnson, Anne
    Huang, Bin
    Lovell, Daniel J.
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (06) : 1163 - 1170
  • [27] Factors for Consideration by Pediatric Rheumatologists When Scoring the Physician Global Assessment of Disease Activity in Juvenile Idiopathic Arthritis: First Step Toward an Internal Consensus
    Tarkiainen, Maarit
    Balay-Dustrude, Erin
    Consolaro, Alessandro
    Morgan, Esi M.
    Ruperto, Nicolino
    Rypdal, Veronika
    Backstrom, Maria
    Vahasalo, Paula
    Gottlieb, Beth S.
    ARTHRITIS CARE & RESEARCH, 2024, : 528 - 533